Emotions From Salivary Biomarkers in an Architectural Context

ConditionEmotions
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSys2Diag

About this trial

Architecture influences our well-being. People's behavior and mood changes in different spaces are directly related to the architectural qualities of the built environment. Neuroarchitecture is a discipline that combines neuroscience and architecture to design spaces adapted to the psychological and physiological needs of users. Several studies related to neuroarchitecture have been conducted according to different architectural parameters such as style, natural environment, lighting, color, and sunlight pattern. Recent studies show that emotional states can be evaluated by physiological responses. This physiological regulation comes from the action of enzymes and hormones that represent the activity of the autonomic nervous system. Measuring specific biomarkers through non-invasive biological tests in saliva provides physiological data on an individual's emotional state in response to stimuli, particularly visual or tactile.

Eligibility criteria

Qualifiers

Subject over 18 years old

Subject agreeing to follow the study procedures

Subject capable of understanding the purpose, nature, and methodology of the study

Subject affiliated with a French social security scheme or beneficiary of such a scheme.

Disqualifiers

Subject not affiliated with a French Social Security scheme or not a beneficiary of such a scheme

Subject deprived of liberty, protected adult, vulnerable person, or minor

Subject with proven or suspected chronic infectious disease that could pose a risk of contamination during sample handling (laboratories not equipped to handle this type of sample)

Subject with a deficiency (vision, anosmia) preventing proper interaction with the architectural work

Trial design

Treatments tested in this trial

  • Bio-fluid analysis for the measurement of salivary biomarkers linked to emotions

Treatment groups

60 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Sys2Diag

Lead sponsor

Centre National de la Recherche Scientifique, France

Collaborator